Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Vitamin D/VDR and Endometrial Decidualization
2026-09-01
The reference study identifies vitamin D receptor signaling as a positive regulator of human endometrial stromal cell decidualization. Its combination of loss- and gain-of-function experiments with ChIP-qPCR supports a mechanism in which VDR enhances aromatase and estrogen-receptor programs that contribute to a receptive endometrial phenotype.
-
EMD638683: A Precision Framework for SGK1 Studies
2026-09-01
EMD638683 is a selective SGK1 inhibitor for dissecting NDRG1 signaling, endothelial stiffness, and stress-related cell responses. This article translates the latest vascular evidence into practical assay-design guidance while defining opportunities and limitations for cancer and hypertension research.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-08-31
HyperFluor 488 Goat Anti-Rabbit IgG is a fluorescent antibody conjugate for detecting rabbit primary antibodies in indirect immunofluorescence, immunocytochemistry, flow cytometry, and related fluorescence workflows. It should be used when the primary antibody is rabbit-derived and the instrument supports the dye, not as a substitute for nonfluorescent detection or a validated reagent for non-rabbit primaries.
-
EMD638683: From SGK1 Inhibition to Vascular Mechanics
2026-08-31
EMD638683 is an SGK1 inhibitor that connects kinase signaling with endothelial stiffness, actin remodeling, and tumor biology. This article interprets the key vascular study and translates its genetic–pharmacological design into more rigorous assay decisions.
-
Annexin V-PE Apoptosis Detection Kit Workflow
2026-08-30
Build a rapid, fixation-free apoptosis workflow for lymphoma pharmacology, cytotoxicity profiling, and live-cell imaging. The Annexin V-PE Apoptosis Detection Kit links phosphatidylserine externalization to flow cytometry and microscopy, helping researchers distinguish an early cell-death response from downstream molecular mechanisms.
-
Chloramphenicol for Plasmid Selection Workflows
2026-08-29
Build cleaner plasmid selection assays with a mechanistically defined bacterial protein synthesis inhibitor. This guide connects chloramphenicol-based plasmid maintenance to plasmid-curing, conjugation, and resistance-surveillance workflows while emphasizing controls, storage, and troubleshooting.
-
ACSL4 and Fatty Acid β-Oxidation in Decidualization
2026-08-28
This 2024 study identifies long-chain acyl-CoA synthetase-4 (ACSL4) as a metabolic regulator of endometrial decidualization. Its experiments show that ACSL4 supports decidualization primarily by promoting fatty acid β-oxidation, rather than by driving lipid droplet accumulation, with implications for understanding uterine receptivity and implantation biology.
-
N4-Acetylcytidine: Reliable RNA Assays
2026-08-28
This scenario-based guide shows how N4-Acetylcytidine, SKU C6648, can support reproducible RNA modification, nucleotide-processing, and cell-phenotype workflows without being confused with a direct viability reagent. It covers solvent selection, concentration calculations, storage, controls, interpretation, and practical supplier comparison.
-
DiscoveryProbe Bioactive Compound Library Plus: Workflow
2026-08-27
Build a practical ligand-screening workflow around 5,072 pre-dissolved bioactive compounds, then connect biophysical hits to pathway-level validation. This guide combines thermal shift assay principles with orthogonal binding, cell-based testing, and troubleshooting for protease, cancer, apoptosis, and inflammatory research.
-
Proteotoxic Cell Death in Advanced Prostate Cancer
2026-08-27
The 2025 Biomedicines study identifies rencofilstat plus ixazomib as a proteotoxic-stress strategy that selectively increases apoptotic death in advanced prostate cancer cells while sparing tested non-cancer cells. Its mechanistic contribution is the integration of cyclophilin biology with unfolded protein response signaling, particularly the time-dependent roles of XBP1s, PERK, phospho-eIF2α, and CD147–ERK signaling.
-
A-769662: Practical AMPK Activation Workflows
2026-08-26
A-769662 is a reversible AMPK activator for linking energy metabolism regulation to fatty acid synthesis, glucose control, autophagy, and proteasome biology. This guide translates its pharmacology into practical dose–response, pathway-validation, troubleshooting, and comparative assay workflows.
-
Triazole ALDH2 Activators for Myocardial Ischemia
2026-08-26
The reference study reports a new triazole scaffold that combines improved aqueous solubility with unusually strong activation of aldehyde dehydrogenase 2 (ALDH2). Lead compound Z17 enhanced cardiac function and reduced biochemical and histological indicators of ischemia-reperfusion injury in mice, supporting further development of ALDH2-directed treatments for myocardial infarction.
-
URB597 in Translational Endocannabinoid Research
2026-08-25
URB597, also known as KDS-4103, offers translational researchers a selective way to interrogate FAAH-dependent anandamide biology. This article connects direct FAAH inhibition with recent evidence from cannabidiol studies in inflammatory pain, while outlining practical strategies for neuroplasticity, neuroinflammation, and endocannabinoid signaling research.
-
Caffeine Workflows for Cancer and Metabolism
2026-08-25
Caffeine (1,3,7-trimethylpurine-2,6-dione) supports dose-resolved cancer cell line inhibition studies, combination testing with valproic acid, and investigations of energy metabolism modulation. This practical guide connects formulation, assay design, metabolic models, and the careful interpretation of cardiovascular evidence without overstating caffeine’s role in ALDH2 research.
-
EMD638683: From SGK1 Signaling to Vascular Translation
2026-08-24
EMD638683 offers translational researchers a selective SGK-family chemical probe for connecting endothelial SGK1 signaling with sodium-channel regulation, actin remodeling, vascular stiffness, and tumor biology. This article interprets recent mechanistic evidence, outlines practical validation workflows, and explains how to position the compound responsibly across hypertension and cancer research.